Literature DB >> 17534837

Incidence of nonarteritic anterior ischemic optic neuropathy in adult Chinese: the Beijing Eye Study.

L Xu1, Y Wang, J B Jonas.   

Abstract

PURPOSE: To determine the incidence of optic nerve damage due to nonarteritic anterior ischemic optic neuropathy (NAION) in the adult Chinese population.
METHODS: The Beijing Eye Study, a population-based, longitudinal study which included 4439 subjects (age 40+ years) in 2006, was repeated in 2006. In the follow-up examination, 3169 (71.4%) subjects participated. Optic disc photographs were assessed. Diagnostic criteria for incident NAION were a small optic disc, segmental pallor, and loss of retinal nerve fiber layer and visual field in the follow-up examination, with a normal optic nerve head appearance at baseline.
RESULTS: New NAION was found in one eye, with an incidence rate of 0.03+/-0.03% per 5 years (mean +/- standard error) (95% confidence interval: -0.03, 0.09), or about 1:16,000 subjects per year.
CONCLUSIONS: Within a 5-year period, new NAION may develop in 1 out of 3200 adult Chinese, or 1:16,000 adult Chinese per year.

Entities:  

Mesh:

Year:  2007        PMID: 17534837     DOI: 10.1177/112067210701700335

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  9 in total

Review 1.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 2.  Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?

Authors:  Konstantinos Hatzimouratidis
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

3.  A primate model of nonarteritic anterior ischemic optic neuropathy.

Authors:  Celia S Chen; Mary A Johnson; Robert A Flower; Bernard J Slater; Neil R Miller; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-07       Impact factor: 4.799

4.  Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.

Authors:  Barbara M Wirostko; Charles Tressler; Lie-Ju Hwang; Gary Burgess; Alan M Laties
Journal:  BMJ       Date:  2012-02-21

5.  Optic nerve head change in non-arteritic anterior ischemic optic neuropathy and its influence on visual outcome.

Authors:  Jost B Jonas; Sohan Singh Hayreh; Yong Tao; Konstantinos I Papastathopoulos; Florian Rensch
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

6.  Clinical Efficacy Observation of Acupuncture Treatment for Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Yali Qin; Wei Yuan; Hui Deng; Zhanmei Xiang; Chao Yang; Xinyun Kou; Shufei Yang; Zhijun Wang; Ming Jin
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-24       Impact factor: 2.629

7.  A rodent model of anterior ischemic optic neuropathy (AION) based on laser photoactivation of verteporfin.

Authors:  Jing-Yu Min; Yanan Lv; Lei Mao; Yuan-Yuan Gong; Qing Gu; Fang Wei
Journal:  BMC Ophthalmol       Date:  2018-11-22       Impact factor: 2.209

8.  Optic Neuritis in the Older Chinese Population: A 5-Year Follow-Up Study.

Authors:  Junqing Wang; Huanfen Zhou; Limin Qin; Chunxia Peng; Jie Zhao; Da Teng; Dahe Lin; Nanping Ai; Quangang Xu; Shihui Wei
Journal:  J Ophthalmol       Date:  2017-12-11       Impact factor: 1.909

9.  Systemic-Related Factors of Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Yue-Yan Xiao; Wen-Bin Wei; Ya-Xing Wang; Ai-Dong Lu; Shuo-Hua Chen; Lu Song; Shou-Ling Wu
Journal:  Chin Med J (Engl)       Date:  2018-10-05       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.